Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)
Clinical trial NCT06959225 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06959225
- Sponsor
- Incyte Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-23
- Primary completion
- 2026-10-09
- Enrollment
- 580
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.